Web Universe
Contact Us
About Ebixa
Key publications
For your patients
Prescribing information
Ebixa is well tolerated
The overall frequency of patients who experienced side-effects was similar with Ebixa compared to placebo.
Ebixa - Efficacy in Alzheimer's disease
In clinical studies, Ebixa has shown to be an efficacious treatment compared with placebo for moderate to severe Alzheimer’s disease.
Ebixa® - The treatment approved for moderate to severe Alzheimer's Disease
Want to know more about Ebixa?
Ebixa is a specific, uncompetitive NMDA-receptor antagonist, and has a novel mechanism of action for the treatment of patients with moderate to severe Alzheimer’s Disease.
Prescribing information
The Prescribing Information outlines the indications of the product, as well as specifics such as dosage, contra-indications, pregnancy and lactation, precautions, drug interactions, adverse events and overdoses.